Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Encephalitis: early-phase trial registry
2 of 5 indexed Encephalitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Encephalitis: 5 US clinical trials tracked, 2 recruiting.
Encephalitis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Bavarian Nordic, running 1 of these trials.
Enrollment posture brief
Registry condition encephalitis
OPEN 2 | RECR 40% | LATE 1 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Encephalitis lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Encephalitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Encephalitis is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Encephalitis research.
Bavarian Nordic accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Encephalitis enrolment sits around 411 participants.
Median target enrolment is 411 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Encephalitis splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
CoMind Early Feasibility Study
CoMind Technologies Limited
NCT06368648
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
University of Utah
NCT04372615
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Bavarian Nordic
NCT06899802
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
Sanofi
NCT00314132
Structure of the Herpes Simplex Virus Receptor
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001648
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Encephalitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Encephalitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Encephalitis page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Encephalitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bavarian Nordic sponsors the most Encephalitis trials on record, review their full trial history before evaluating a specific study. See Bavarian Nordic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Encephalitis condition card totals 5 registered trials; most-linked intervention 0.9% Saline; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.